Cargando…

The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study

SARS-CoV-2 is a rapidly evolving pathogen that has caused a global pandemic characterized by several consecutive waves. Based on epidemiological and NGS data, many different variants of SARS-CoV-2 were described and characterized since the original variant emerged in Wuhan in 2019. Notably, SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksenova, Anna Y., Likhachev, Ilya V., Grishin, Sergei Y., Galzitskaya, Oxana V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655063/ https://www.ncbi.nlm.nih.gov/pubmed/36362302 http://dx.doi.org/10.3390/ijms232113502

Ejemplares similares

Identification of Amyloidogenic Regions in Pseudomonas aeruginosa Ribosomal S1 Protein
por: Grishin, Sergei Y., et al.
Publicado: (2021)

Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2?
por: Kurpe, Stanislav R., et al.
Publicado: (2020)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Exploring Amyloidogenicity of Peptides From Ribosomal S1 Protein to Develop Novel AMPs
por: Galzitskaya, Oxana V.
Publicado: (2021)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

Amyloidogenic Propensities of Ribosomal S1 Proteins: Bioinformatics Screening and Experimental Checking
por: Grishin, Sergei Y., et al.
Publicado: (2020)

Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant
por: Samanta, Arijit, et al.
Publicado: (2022)

Prediction of Amyloidogenic and Disordered Regions in Protein Chains
por: Galzitskaya, Oxana V, et al.
Publicado: (2006)

Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
por: Han, Pengcheng, et al.
Publicado: (2022)

Disordered Residues and Patterns in the Protein Data Bank
por: Lobanov, Mikhail Yu., et al.
Publicado: (2020)

Is It Possible to Find an Antimicrobial Peptide That Passes the Membrane Bilayer with Minimal Force Resistance? An Attempt at a Predictive Approach by Molecular Dynamics Simulation
por: Likhachev, Ilya V., et al.
Publicado: (2022)

Amyloidogenic Peptides: New Class of Antimicrobial Peptides with the Novel Mechanism of Activity
por: Galzitskaya, Oxana V., et al.
Publicado: (2022)

Neohesperidin and spike RBD interaction in omicron and its sub-variants: In silico, structural and simulation studies
por: Singh, Jaikee Kumar, et al.
Publicado: (2023)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

In silico study of intrinsic dynamics of full-length apo-ACE2 and RBD-ACE2 complex
por: Liu, Qing, et al.
Publicado: (2021)

Mechanism of Amyloid Gel Formation by Several Short Amyloidogenic Peptides
por: Galzitskaya, Oxana V., et al.
Publicado: (2021)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

Dataset of the molecular dynamics simulations of bilayers consisting of short amyloidogenic peptide VDSWNVLVAG from Bgl2p–glucantransferase of S. cerevisiae cell wall
por: Glyakina, Anna V., et al.
Publicado: (2016)

Molecular dynamic simulation suggests stronger interaction of Omicron-spike with ACE2 than wild but weaker than Delta SARS-CoV-2 can be blocked by engineered S1-RBD fraction
por: Santra, Dipannita, et al.
Publicado: (2022)

Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of P. aeruginosa?
por: Grishin, Sergei Y., et al.
Publicado: (2021)

Antimicrobial and Amyloidogenic Activity of Peptides Synthesized on the Basis of the Ribosomal S1 Protein from Thermus Thermophilus
por: Kurpe, Stanislav R., et al.
Publicado: (2020)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants
por: Sang, Peng, et al.
Publicado: (2022)

Quantitative in silico analysis of SARS-CoV-2 S-RBD omicron mutant transmissibility
por: Hanai, Toshihiko
Publicado: (2022)

Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike
por: Banerjee, Amrita, et al.
Publicado: (2022)

Large interfacial relocation in RBD-ACE2 complex may explain fast-spreading property of Omicron
por: Shirzadeh, Maryam, et al.
Publicado: (2022)

Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
por: Philip, Angelin M., et al.
Publicado: (2023)

Is there an advantageous arrangement of aromatic residues in proteins? Statistical analysis of aromatic interactions in globular proteins
por: Lobanov, Mikhail Yu., et al.
Publicado: (2021)

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19
por: BR, Bharath, et al.
Publicado: (2020)

Targeting CoV-2 spike RBD and ACE-2 interaction with flavonoids of Anatolian propolis by in silico and in vitro studies in terms of possible COVID-19 therapeutics
por: GÜLER, Halil İbrahim, et al.
Publicado: (2021)

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
por: Lupala, Cecylia S., et al.
Publicado: (2022)

Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2
por: Rathod, Shravan B., et al.
Publicado: (2020)

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
por: Cao, Wenpeng, et al.
Publicado: (2021)

A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD—ACE2 Interaction
por: Fernandez-Fuentes, Narcis, et al.
Publicado: (2021)

Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern
por: Kim, Seonghan, et al.
Publicado: (2021)

Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern
por: Kim, Seonghan, et al.
Publicado: (2022)

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2021)

Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants
por: da Costa, Clauber Henrique Souza, et al.
Publicado: (2022)

Determination of amyloid core regions of insulin analogues fibrils
por: Surin, Alexey K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3qhoej3gmt47ucg0nnd2or97r5